Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00032279
Recruitment Status : Unknown
Verified October 2003 by Facet Biotech.
Recruitment status was:  Active, not recruiting
First Posted : March 18, 2002
Last Update Posted : June 24, 2005
Facet Biotech
Information provided by:
Facet Biotech

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : No date given